Skip to main content
CreoSG Co.,Ltd. logo

CreoSG Co.,Ltd. — Investor Relations & Filings

Ticker · 040350 ISIN · KR7040350001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 355 across all filing types
Latest filing 2022-03-14 Audit Report / Informat…
Country KR South Korea
Listing KO 040350

About CreoSG Co.,Ltd.

https://www.creosg.com/

CreoSG Co., Ltd. is a company with two primary business divisions: IT solutions and biotechnology. The IT solutions division specializes in providing services to financial institutions, focusing on the development and implementation of next-generation systems, application development, and IT outsourcing. The biotechnology division is dedicated to the research and development of vaccines. Its main pipeline includes an HIV/AIDS vaccine candidate and a COVID-19 vaccine. The company's vaccine development is based on its proprietary recombinant Vesicular Stomatitis Virus (VSV) vector system, which serves as its core technological platform.

Recent filings

Filing Released Lang Actions
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the company 'Curocom' (주식회사 큐로컴) for the fiscal year ending December 31, 2021. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. This is a full financial audit document, not an earnings release or a summary, and it is clearly identified as an audit report by the header and the inclusion of the auditor's opinion. FY 2021
2022-03-14 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation & Information Statement' (의결권대리행사권유참고서류) filed by Curocom. It contains detailed financial statements (consolidated balance sheets, income statements, cash flow statements) and notes to the financial statements as part of the materials provided to shareholders for the upcoming general meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI) as it is designed to provide shareholders with necessary information to exercise their voting rights.
2022-03-14 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a '주주총회소집공고 정정신고' (Notice of Convocation of General Meeting of Shareholders - Amendment Report) filed by Curocom Co., Ltd. It contains detailed financial statements (consolidated balance sheets, income statements, cash flow statements) and notes to the financial statements, which are being corrected following an external audit. While it is related to an AGM, the primary content is the disclosure of audited financial data and management's explanation of the corrections. In the context of Korean regulatory filings (DART), this is a comprehensive financial disclosure document. Given the detailed financial reporting and audit-related corrections, it is classified as a Financial Report (FS) or, more broadly, a Regulatory Filing (RNS). However, since it contains the full financial statements and notes, it aligns most closely with the 'Financial Supplement Data' or 'Regulatory Filings' category. Given the specific nature of the corrections to financial statements, 'RNS' is the most appropriate fallback for this regulatory filing.
2022-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a change in financial results (revenue or profit/loss structure) by more than 30%. It provides a comparative table of financial data between the current and previous fiscal years, explains the reasons for the changes, and notes that these figures reflect the external auditor's results. This is a standard regulatory disclosure for material financial changes, which falls under the 'Earnings Release' category as it provides the initial announcement of financial performance highlights. FY 2021
2022-03-14 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation & Information Statement' (의결권대리행사권유참고서류) filed by Curocom Co., Ltd. It contains details regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures, and information about the solicitors. This document is specifically designed to solicit proxies from shareholders for the meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2022-03-10 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Curocom) regarding a 'Single Sale/Supply Contract' amendment. It details a change in contract value (correction report). Since this is a specific regulatory disclosure regarding a business contract and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-03-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.